Ferrán
Navarro Risueño
Publicacións nas que colabora con Ferrán Navarro Risueño (26)
2022
2020
-
Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae
Microbial Genomics, Vol. 6, Núm. 5, pp. 1-18
-
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
Scientific Reports, Vol. 10, Núm. 1
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
2018
-
Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop
Microbial Drug Resistance, Vol. 24, Núm. 5, pp. 527-533
2017
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Empiric Therapy with Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results from the INCREMENT Cohort
Clinical Infectious Diseases, Vol. 65, Núm. 10, pp. 1615-1623
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
Prevalence of quinolone resistance mechanisms in Enterobacteriaceae producing acquired AmpC β-lactamases and/or carbapenemases in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 8, pp. 487-492
2016
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
Mobile genetic elements related to the diffusion of plasmid-mediated AmpC β-lactamases or carbapenemases from enterobacteriaceae: Findings from a multicenter study in Spain
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 9, pp. 5260-5266
-
Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain
International Journal of Antimicrobial Agents, Vol. 46, Núm. 2, pp. 157-163
-
Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem
Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 6, pp. 3406-3412
-
Rates of faecal colonization by carbapenemase-producing enterobacteriaceae among patients admitted to ICUs in Spain
Journal of Antimicrobial Chemotherapy
2014
-
Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7
Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 11, pp. 6544-6549
-
Inhibitor-resistant TEM- And OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates
Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 7, pp. 3874-3881
2013
-
Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 Loop that affects ceftazidime hydrolysis
Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 10, pp. 5158-5161